Heme_arginate

Heme arginate

Heme arginate

Chemical compound

Heme arginate (or haem arginate) is a compound of heme and arginine used in the treatment of acute porphyrias.[1][2] This heme product is only available outside the United States and is equivalent to hematin.[3]

Quick Facts Identifiers, Properties ...

Heme arginate is a heme compound, whereby L-arginine is added to prevent rapid degradation. It is given intravenously, and its action of mechanism is to reduce the overproduction of δ-aminolevulinic acid, which can cause the acute symptoms in an attack of the acute porphyrias.[4]

See also

References

  1. [1]
    "HAEM ARGINATE FOR THE ACUTE ATTACK OF PORPHYRIA". Porphyria South Africa. Archived from the original on 2012-03-05.
  2. [2]
    "Treatment of the Acute Attack". European Porphyria Network. Archived from the original on 5 October 2011. Retrieved 28 August 2011.
  3. [3]
    "Panhematin for Acute Porphyria". American Porphyria Foundation. Retrieved 8 July 2016.
  4. [4]
    Volin, L; V Rasi; E Vahtera; R Tenhunen (1988). "Heme arginate: effects on hemostasis" (PDF). Blood. 71 (3): 625–628. doi:10.1182/blood.V71.3.625.625. PMID 3345341. Retrieved 28 August 2011.
Share this article:

This article uses material from the Wikipedia article Heme_arginate, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.